Track market-moving stories before they get noisy

LEAWOOD, Kan.--(BUSINESS WIRE)---- $AMC--AMC Entertainment Holdings, Inc. (NYSE: AMC) (“AMC” or “the Company”), announced today that it has completed its previously disclosed $150 million at-the-market (“ATM”) equity offering launched on February 9, 2026. AMC raised $150.0 million of new equity capital through the sale of approximately 105.3 million shares, before commissions and fees.The completion of this ATM equity offering boosts AMC's cash position and further strengthens our balance sheet. Coupled.

Global study of 1,000 robotics developers reveals growing focus on software foundations to address performance, security, and scalability challenges Key Findings from the "Inside the Robot: Architecture Benchmark Report": Nearly nine in ten robotics developers (89%) say Physical AI is critical to their future plans. Deterministic, real-time behaviour is essential for 95% of robotics developers.

BlackBerry Limited (BB) is positioned to benefit from the rise of physical AI, with QNX poised as a leading robotics operating system. QNX sales grew 14% in FY26 and 20% in Q4, supported by a $950 million backlog, signaling a successful turnaround and accelerating growth. BB's strong balance sheet, net cash of $232 million, and ongoing share buybacks enhance downside protection and capital allocation.

BlackBerry surged 8.53% after hours as FedRAMP recertification, director DSU purchases and strong momentum fueled investor interest.

BlackBerry's 153.2% run is buoyed by strong performance as QNX posts record backlog, while Secure Comms shows renewed growth.

BlackBerry Ltd (NYSE: BB) shares are trading lower in Thursday's premarket as traders cool after a breakout run to fresh 52-week highs.

BlackBerry Ltd (NYSE:BB) shares are trading lower during Friday's premarket session as traders cool off after a sharp breakout run that recently pushed the stock into fresh 52-week-high territory.

BlackBerry (BB) has completed its turnaround, now positioning itself as a growth company focused on its QNX software platform. BB's valuation is elevated after a 180% rally, trading at 67.21x forward P/E and 10.12x forward P/S, well above sector medians. Management guides for FY2027 QNX revenue of ~$300M (15% growth), targeting expansion in automotive, robotics, and medical sectors.

CHARLOTTE, N.C.--(BUSINESS WIRE)--Just in time for National Iced Tea Day, Bojangles is introducing two sweet ways to enjoy summer with the launch of its new Peach Iced Tea and Blackberry Cobbler, available for a limited time at participating restaurants. Crafted with Bojangles Legendary Iced Tea®, steeped the old-fashioned way and sweetened with peach puree, the new Peach Iced Tea delivers a crisp, refreshing sip that captures the taste of summer in every cup. National Iced Tea Day is the perfe.

On CNBC's “Mad Money Lightning Round,” Jim Cramer said BlackBerry Limited (NYSE:BB) is “good.”

WATERLOO, ON / ACCESS Newswire / June 11, 2026 / BlackBerry Limited (NYSE:BB)(TSX:BB) will hold its Annual General Meeting (AGM) virtually on June 25, 2026, at 10:00 am ET. Shareholders can access the live audio webcast and voting platform at meetnow.global/MJSLNAS.

/PRNewswire/ -- Компания Amgen (NASDAQ: AMGN) сегодня объявила, что Европейская комиссия (ЕК) выдала регистрационное удостоверение на препарат IMDYLLTRA

THOUSAND OAKS, Calif., June 4, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 47th Annual Global Healthcare Conference at 9:20 a.m.

Amgen Inc. is upgraded to a cautious Buy, reflecting improved fundamentals, a diversified pipeline, and a decent risk/reward profile despite recent underperformance versus the S&P. Key growth drivers include Imdelltra, Uplizna, Tepezza, Repatha, and the promising but unproven Maritide, offsetting declines from legacy drugs like Prolia. AMGN's robust R&D pipeline, margin expansion, and capital investments are positioning the company for sustained long-term growth, though high debt and capex warrant monitoring.

VESALIUS-CV Subgroup Results Show Repatha ® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes New Real-World Data Highlight Treatment Gaps in Current Obesity and Diabetes Care THOUSAND OAKS, Calif., June 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data at the American Diabetes Association (ADA) 86th Scientific Sessions reinforcing its commitment to addressing unmet needs for people living with cardiometabolic conditions and improving patient outcomes.

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Amgen NASDAQ: AMGN executives said the company's first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for the denosumab franchise and other losses of exclusivity.

MariTide's less frequent dosing could help AMGN carve out a place in the rapidly expanding obesity drug market.

Amgen said it has signed up a research firm to independently review data for its drug, Tavneos, as it seeks to ​prove its benefits following the U.S. health regulator's ‌proposal to withdraw it from the market.

Law Offices of Howard G. Smith continues its investigation on behalf of Upwork Inc. (“Upwork” or the “Company”) (NASDAQ: [url="]UPWK[/url]) investors co

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Shareholders who held Upwork Inc. (NASDAQ: UPWK) stock lost approximately 19% of their investment value when shares plunged after the Company reported Q1 2026 earnings that fell short of consensus estimates and cut its forward guidance.

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Upwork Inc. ("Upwork" or the "Company") (NASDAQ: UPWK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) --  Pomerantz LLP is investigating claims on behalf of investors of Upwork Inc. (“Upwork” or the “Company”) (NASDAQ: UPWK). Such investors are advised to contact Danielle Peyton at [email protected]  or 646-581-9980, ext. 7980.

NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Upwork Inc. ("Upwork" or the "Company") (NASDAQ: UPWK).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Upwork Inc.